Connection

Antonio Gasbarrini to Humans

This is a "connection" page, showing publications Antonio Gasbarrini has written about Humans.
Connection Strength

0.502
  1. Real-life survey on severe asthma patients during COVID-19 lockdown in Italy. Expert Rev Respir Med. 2021 08; 15(8):1057-1060.
    View in: PubMed
    Score: 0.008
  2. Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use. PLoS One. 2021; 16(1):e0245281.
    View in: PubMed
    Score: 0.007
  3. Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection. Gastroenterology. 2021 04; 160(5):1891-1893.
    View in: PubMed
    Score: 0.007
  4. Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features. BMC Infect Dis. 2020 Oct 19; 20(1):775.
    View in: PubMed
    Score: 0.007
  5. The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7519-7523.
    View in: PubMed
    Score: 0.007
  6. Off-label use of tocilizumab in patients with SARS-CoV-2 infection. J Med Virol. 2020 10; 92(10):1787-1788.
    View in: PubMed
    Score: 0.007
  7. Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past? Eur Rev Med Pharmacol Sci. 2020 06; 24(12):7194-7195.
    View in: PubMed
    Score: 0.007
  8. Editorial - COVID-19 and the microbiota: new kids on the block. Eur Rev Med Pharmacol Sci. 2020 05; 24(9):5189-5191.
    View in: PubMed
    Score: 0.007
  9. Wire-guided biliary cannulation: a comprehensive approach to a set of techniques. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1299-1305.
    View in: PubMed
    Score: 0.007
  10. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies. Eur Rev Med Pharmacol Sci. 2019 May; 23(9):4002-4009.
    View in: PubMed
    Score: 0.007
  11. A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial. Nutrients. 2019 Mar 27; 11(4).
    View in: PubMed
    Score: 0.007
  12. Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(1):426-430.
    View in: PubMed
    Score: 0.006
  13. Medicine in the time of Carracci: the cases of Domenico Lanzoni and Giuseppe Rosaccio. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):464-470.
    View in: PubMed
    Score: 0.006
  14. Clinical assessment and management of severe acute pancreatitis: a multi-disciplinary approach in the XXI century. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):771-787.
    View in: PubMed
    Score: 0.006
  15. Antibiotic and Modulation of Microbiota: A New Paradigm? J Clin Gastroenterol. 2018 Nov/Dec; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S74-S77.
    View in: PubMed
    Score: 0.006
  16. Polymethylmethacrylate-augmented fenestreted pedicle-screw fixation in low bone quality patients: a case series and literature review. J Biol Regul Homeost Agents. 2018 Nov-Dec; 32(6 Suppl. 1):71-76.
    View in: PubMed
    Score: 0.006
  17. Regorafenib: a promising treatment for hepatocellular carcinoma. Expert Opin Pharmacother. 2018 Dec; 19(17):1941-1948.
    View in: PubMed
    Score: 0.006
  18. ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study. Dig Liver Dis. 2019 02; 51(2):293-296.
    View in: PubMed
    Score: 0.006
  19. Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2018 Aug 12; 10(8).
    View in: PubMed
    Score: 0.006
  20. Considering gut microbiota disturbance in the management of Helicobacter pylori infection. Expert Rev Gastroenterol Hepatol. 2018 Sep; 12(9):899-906.
    View in: PubMed
    Score: 0.006
  21. The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease. Expert Opin Investig Drugs. 2018 06; 27(6):543-551.
    View in: PubMed
    Score: 0.006
  22. Helicobacter pylori in metabolic related diseases. Minerva Gastroenterol Dietol. 2018 Sep; 64(3):297-309.
    View in: PubMed
    Score: 0.006
  23. Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals. Dig Liver Dis. 2018 07; 50(7):635-639.
    View in: PubMed
    Score: 0.006
  24. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Dig Liver Dis. 2018 May; 50(5):421-428.
    View in: PubMed
    Score: 0.006
  25. Risk factors for gastric cancer: is it time to discard PPIs? Gut. 2019 01; 68(1):176-177.
    View in: PubMed
    Score: 0.006
  26. Sarcopenia in Patients with Advanced Liver Disease. Curr Protein Pept Sci. 2018; 19(7):681-691.
    View in: PubMed
    Score: 0.006
  27. Proteobacteria: A Common Factor in Human Diseases. Biomed Res Int. 2017; 2017:9351507.
    View in: PubMed
    Score: 0.006
  28. Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
    View in: PubMed
    Score: 0.006
  29. Rifaximin Re-treatment in Patients with Irritable Bowel Syndrome: Feels Like the First Time? Dig Dis Sci. 2017 09; 62(9):2220-2222.
    View in: PubMed
    Score: 0.006
  30. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter. 2017 Sep; 22 Suppl 1.
    View in: PubMed
    Score: 0.006
  31. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders. Dig Dis. 2018; 36(1):56-65.
    View in: PubMed
    Score: 0.006
  32. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World J Gastroenterol. 2017 Jul 07; 23(25):4491-4499.
    View in: PubMed
    Score: 0.006
  33. The gut microbiota: its anatomy and physiology over a lifetime. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):329-336.
    View in: PubMed
    Score: 0.006
  34. How to modulate gut microbiota: diet, preprobiotics or antibiotics? Minerva Gastroenterol Dietol. 2017 Dec; 63(4):411-419.
    View in: PubMed
    Score: 0.006
  35. Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? World J Gastroenterol. 2016 Dec 14; 22(46):10198-10209.
    View in: PubMed
    Score: 0.006
  36. The healthcare service in Italy: regional variability. Eur Rev Med Pharmacol Sci. 2016 12; 20(1 Suppl):1-3.
    View in: PubMed
    Score: 0.006
  37. Role of fecal calprotectin in gastrointestinal disorders. Eur Rev Med Pharmacol Sci. 2013 Jun; 17(12):1569-82.
    View in: PubMed
    Score: 0.004
  38. [Chronic hepatitis C virus infection: clinical picture and treatment possibilities]. G Ital Nefrol. 2012 Jan-Feb; 29 Suppl 54:S103-8.
    View in: PubMed
    Score: 0.004
  39. Stem cell-based therapy in gastroenterology and hepatology. Minim Invasive Ther Allied Technol. 2008; 17(2):100-18.
    View in: PubMed
    Score: 0.003
  40. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005 Dec 14; 11(46):7227-36.
    View in: PubMed
    Score: 0.003
  41. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005 Dec; 22(11-12):1157-60.
    View in: PubMed
    Score: 0.003
  42. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol. 2005 Apr; 100(4):886-95.
    View in: PubMed
    Score: 0.002
  43. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct; 8(5):231-3.
    View in: PubMed
    Score: 0.002
  44. Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol. 2003 Mar; 98(3):625-9.
    View in: PubMed
    Score: 0.002
  45. Helicobacter pylori and extragastric diseases -- other helicobacters. Helicobacter. 2003; 8 Suppl 1:68-76.
    View in: PubMed
    Score: 0.002
  46. Osteoid osteoma of L4: excision by videoendoscopy. Chir Organi Mov. 2002 Jul-Sep; 87(3):195-202.
    View in: PubMed
    Score: 0.002
  47. Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey. Int J Clin Pract. 2021 Nov; 75(11):e14755.
    View in: PubMed
    Score: 0.002
  48. Occupational hand dermatitis web survey in a university hospital during COVID-19 pandemic: the SHIELD study. Med Lav. 2021 Aug 26; 112(4):320-326.
    View in: PubMed
    Score: 0.002
  49. Diet Intervention Study through Telemedicine Assistance for Systemic Nickel Allergy Syndrome Patients during the COVID-19 Pandemic. Nutrients. 2021 Aug 23; 13(8).
    View in: PubMed
    Score: 0.002
  50. Frailty Assessment in the Emergency Department for Risk Stratification of COVID-19 Patients Aged =80 Years. J Am Med Dir Assoc. 2021 09; 22(9):1845-1852.e1.
    View in: PubMed
    Score: 0.002
  51. Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? Aging Clin Exp Res. 2021 Aug; 33(8):2335-2343.
    View in: PubMed
    Score: 0.002
  52. COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. JCI Insight. 2021 06 18; 6(13).
    View in: PubMed
    Score: 0.002
  53. Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. Dig Liver Dis. 2021 11; 53(11):1428-1432.
    View in: PubMed
    Score: 0.002
  54. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI). Intern Emerg Med. 2021 Jun; 16(4):1005-1015.
    View in: PubMed
    Score: 0.002
  55. The Role of Nutrition in the COVID-19 Pandemic. Nutrients. 2021 Mar 27; 13(4).
    View in: PubMed
    Score: 0.002
  56. Effect of influenza vaccine on COVID-19 mortality: a retrospective study. Intern Emerg Med. 2021 10; 16(7):1849-1855.
    View in: PubMed
    Score: 0.002
  57. Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged = 80 YEARs OLD. Arch Gerontol Geriatr. 2021 Jul-Aug; 95:104383.
    View in: PubMed
    Score: 0.002
  58. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients. Dig Liver Dis. 2021 05; 53(5):541-544.
    View in: PubMed
    Score: 0.002
  59. SARS-CoV-2 vaccines and donor recruitment for FMT. Lancet Gastroenterol Hepatol. 2021 04; 6(4):264-266.
    View in: PubMed
    Score: 0.002
  60. Web-mediated counseling to counteract the emotional impact of COVID-19 for women with interstitial cystitis/bladder pain syndrome. Eur Rev Med Pharmacol Sci. 2021 Feb; 25(4):2109-2113.
    View in: PubMed
    Score: 0.002
  61. Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients. Gastroenterology. 2021 07; 161(1):368-369.
    View in: PubMed
    Score: 0.002
  62. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19. Intern Med J. 2020 12; 50(12):1483-1491.
    View in: PubMed
    Score: 0.002
  63. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13072-13088.
    View in: PubMed
    Score: 0.002
  64. Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores. J Am Geriatr Soc. 2021 01; 69(1):37-43.
    View in: PubMed
    Score: 0.002
  65. Surgical emergencies during SARS-CoV-2 pandemic lockdown: what happened? Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11919-11925.
    View in: PubMed
    Score: 0.002
  66. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Oct 22; 21(1):875.
    View in: PubMed
    Score: 0.002
  67. Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020 10; 115(10):1722-1724.
    View in: PubMed
    Score: 0.002
  68. Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19):10225-10227.
    View in: PubMed
    Score: 0.002
  69. Role of troponin in COVID-19 pandemic: a review of literature. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19):10293-10300.
    View in: PubMed
    Score: 0.002
  70. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis. 2020 12; 52(12):1390-1395.
    View in: PubMed
    Score: 0.002
  71. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel. Scand J Immunol. 2021 Mar; 93(3):e12977.
    View in: PubMed
    Score: 0.002
  72. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis. Dig Liver Dis. 2020 12; 52(12):1383-1389.
    View in: PubMed
    Score: 0.002
  73. Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores. Resuscitation. 2020 11; 156:84-91.
    View in: PubMed
    Score: 0.002
  74. Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis. J Thromb Haemost. 2020 09; 18(9):2358-2363.
    View in: PubMed
    Score: 0.002
  75. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020 08 20; 26(9):1306-1314.
    View in: PubMed
    Score: 0.002
  76. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br J Haematol. 2020 10; 191(2):207-211.
    View in: PubMed
    Score: 0.002
  77. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Aliment Pharmacol Ther. 2020 09; 52(6):1060-1068.
    View in: PubMed
    Score: 0.002
  78. Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic. J Ultrasound. 2020 Dec; 23(4):449-456.
    View in: PubMed
    Score: 0.002
  79. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut. 2020 09; 69(9):1555-1563.
    View in: PubMed
    Score: 0.002
  80. Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID-19 pandemic. J Thromb Haemost. 2020 07; 18(7):1799-1801.
    View in: PubMed
    Score: 0.002
  81. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive. J Infect. 2021 01; 82(1):159-198.
    View in: PubMed
    Score: 0.002
  82. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
    View in: PubMed
    Score: 0.002
  83. NAFLD or comorbidities, that is the question. J Hepatol. 2020 09; 73(3):723.
    View in: PubMed
    Score: 0.002
  84. Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. Lancet Gastroenterol Hepatol. 2020 05; 5(5):430-432.
    View in: PubMed
    Score: 0.002
  85. Takotsubo Syndrome and Inflammatory Bowel Diseases: Does a Link Exist? Dig Dis. 2020; 38(3):204-210.
    View in: PubMed
    Score: 0.002
  86. Predictors of mortality of bloodstream infections among internal medicine patients: Mind the complexity of the septic population! Eur J Intern Med. 2019 10; 68:e22-e23.
    View in: PubMed
    Score: 0.002
  87. Madelung's disease and acute alcoholic hepatitis: case report and review of literature. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6272-6276.
    View in: PubMed
    Score: 0.002
  88. Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6379-6386.
    View in: PubMed
    Score: 0.002
  89. The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study. Liver Int. 2019 08; 39(8):1478-1489.
    View in: PubMed
    Score: 0.002
  90. Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients. Expert Opin Drug Saf. 2019 Aug; 18(8):753-758.
    View in: PubMed
    Score: 0.002
  91. Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence. Eur Rev Med Pharmacol Sci. 2019 Jun; 23(12):5343-5350.
    View in: PubMed
    Score: 0.002
  92. MEDS score and vitamin D status are independent predictors of mortality in a cohort of Internal Medicine patients with microbiological identified sepsis. Eur Rev Med Pharmacol Sci. 2019 May; 23(9):4033-4043.
    View in: PubMed
    Score: 0.002
  93. Spondylodiscitis: is really all well defined? Eur Rev Med Pharmacol Sci. 2019 Apr; 23(2 Suppl):201-209.
    View in: PubMed
    Score: 0.002
  94. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci. 2019 Apr; 23(7):2986-3000.
    View in: PubMed
    Score: 0.002
  95. Anti-tumor necrosis factor a therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol. 2019 Mar 28; 25(12):1465-1477.
    View in: PubMed
    Score: 0.002
  96. Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines. J Biol Regul Homeost Agents. 2019 Mar-Apr,; 33(2):315-319.
    View in: PubMed
    Score: 0.002
  97. Isthmic spondylolisthesis and interspinous process device. Hype, hope, or contraindication? Eur Rev Med Pharmacol Sci. 2019 Mar; 23(6):2340-2344.
    View in: PubMed
    Score: 0.002
  98. Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. World J Gastroenterol. 2019 Jan 28; 25(4):509-520.
    View in: PubMed
    Score: 0.002
  99. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer. Int J Mol Sci. 2019 Jan 24; 20(3).
    View in: PubMed
    Score: 0.002
  100. Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center. Int J Infect Dis. 2019 Mar; 80:105-110.
    View in: PubMed
    Score: 0.002
  101. Real life experiences in HCV management in 2018. Expert Rev Anti Infect Ther. 2019 02; 17(2):117-128.
    View in: PubMed
    Score: 0.002
  102. Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? Int J Mol Sci. 2019 Jan 06; 20(1).
    View in: PubMed
    Score: 0.002
  103. Acute HEV hepatitis: clinical and laboratory diagnosis. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):764-770.
    View in: PubMed
    Score: 0.002
  104. Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. Eur Rev Med Pharmacol Sci. 2019 Jan; 23(2):795-810.
    View in: PubMed
    Score: 0.002
  105. Eosinophilic oesophagitis (in nickel-allergic patient) regressed after nickel oral desensitization: A case report. Int J Immunopathol Pharmacol. 2019 Jan-Dec; 33:2058738419827771.
    View in: PubMed
    Score: 0.002
  106. Management of celiac disease in daily clinical practice: do not forget depression! Eur J Intern Med. 2019 04; 62:e17.
    View in: PubMed
    Score: 0.002
  107. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019 02; 51(2):190-205.
    View in: PubMed
    Score: 0.002
  108. [Microbiota and inflammatory bowel disease: an update.] Recenti Prog Med. 2018 Dec; 109(12):570-573.
    View in: PubMed
    Score: 0.002
  109. The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut?Retina Axis. Nutrients. 2018 Nov 05; 10(11).
    View in: PubMed
    Score: 0.002
  110. Gut microbiota and aging. Eur Rev Med Pharmacol Sci. 2018 11; 22(21):7404-7413.
    View in: PubMed
    Score: 0.002
  111. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment Pharmacol Ther. 2018 12; 48(11-12):1301-1311.
    View in: PubMed
    Score: 0.002
  112. Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol. Molecules. 2018 Oct 20; 23(10).
    View in: PubMed
    Score: 0.002
  113. Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study. Hepatology. 2018 10; 68(4):1232-1244.
    View in: PubMed
    Score: 0.002
  114. Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn's Disease. Int J Mol Sci. 2018 Sep 26; 19(10).
    View in: PubMed
    Score: 0.002
  115. IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair. Proc Natl Acad Sci U S A. 2018 10 02; 115(40):E9362-E9370.
    View in: PubMed
    Score: 0.002
  116. Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel. Inflamm Bowel Dis. 2018 09 15; 24(10):2198-2210.
    View in: PubMed
    Score: 0.002
  117. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases. Expert Rev Clin Immunol. 2018 09; 14(9):751-759.
    View in: PubMed
    Score: 0.002
  118. Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis. J Viral Hepat. 2018 12; 25(12):1493-1500.
    View in: PubMed
    Score: 0.002
  119. May nutritional status worsen during hospital stay? A sub-group analysis from a cross-sectional study. Intern Emerg Med. 2019 Jan; 14(1):51-57.
    View in: PubMed
    Score: 0.002
  120. Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study. Dig Liver Dis. 2019 02; 51(2):218-225.
    View in: PubMed
    Score: 0.002
  121. Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? Liver Int. 2018 12; 38(12):2190-2198.
    View in: PubMed
    Score: 0.002
  122. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-a on the Liver. Int J Mol Sci. 2018 Jul 27; 19(8).
    View in: PubMed
    Score: 0.002
  123. Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases. Minerva Gastroenterol Dietol. 2018 Dec; 64(4):351-362.
    View in: PubMed
    Score: 0.002
  124. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. Hepatology. 2019 01; 69(1):107-120.
    View in: PubMed
    Score: 0.002
  125. The use of single balloon enteroscopy in Crohn's disease and its impact on clinical outcome. Scand J Gastroenterol. 2018 Aug; 53(8):925-929.
    View in: PubMed
    Score: 0.002
  126. Long-term pancreatic exocrine and endometabolic functionality after pancreaticoduodenectomy. Comparison between pancreaticojejunostomy and pancreatic duct occlusion with fibrin glue. Eur Rev Med Pharmacol Sci. 2018 07; 22(13):4310-4318.
    View in: PubMed
    Score: 0.002
  127. Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. Crit Rev Oncol Hematol. 2018 Sep; 129:54-66.
    View in: PubMed
    Score: 0.002
  128. Metabolic disorders across hepatocellular carcinoma in Italy. Liver Int. 2018 11; 38(11):2028-2039.
    View in: PubMed
    Score: 0.002
  129. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications. Expert Rev Gastroenterol Hepatol. 2018 Jul; 12(7):641-656.
    View in: PubMed
    Score: 0.002
  130. Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review. Semin Liver Dis. 2018 05; 38(2):145-159.
    View in: PubMed
    Score: 0.002
  131. Impact of patients nutritional status on major surgery outcome. Eur Rev Med Pharmacol Sci. 2018 06; 22(11):3524-3533.
    View in: PubMed
    Score: 0.002
  132. The ten commandments of liver ablation: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018 06; 22(12):3896-3904.
    View in: PubMed
    Score: 0.002
  133. Risk, prevalence, and impact of hospital malnutrition in a Tertiary Care Referral University Hospital: a cross-sectional study. Intern Emerg Med. 2018 08; 13(5):689-697.
    View in: PubMed
    Score: 0.002
  134. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Aliment Pharmacol Ther. 2018 07; 48(2):152-159.
    View in: PubMed
    Score: 0.002
  135. Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. Infection. 2018 Oct; 46(5):607-615.
    View in: PubMed
    Score: 0.002
  136. Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study. BMC Infect Dis. 2018 05 16; 18(1):223.
    View in: PubMed
    Score: 0.002
  137. Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index. Eur Rev Med Pharmacol Sci. 2018 05; 22(10):3160-3165.
    View in: PubMed
    Score: 0.002
  138. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Dig Liver Dis. 2018 08; 50(8):741-749.
    View in: PubMed
    Score: 0.002
  139. Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? J Transl Med. 2018 04 17; 16(1):102.
    View in: PubMed
    Score: 0.002
  140. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice. Hepatology. 2018 05; 67(5):1784-1796.
    View in: PubMed
    Score: 0.002
  141. Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). Dig Liver Dis. 2018 Aug; 50(8):761-767.
    View in: PubMed
    Score: 0.002
  142. Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications. Gynecol Oncol. 2018 05; 149(2):263-269.
    View in: PubMed
    Score: 0.002
  143. Treatment of early stage chronic hepatitis C virus infection. Expert Rev Clin Pharmacol. 2018 May; 11(5):519-524.
    View in: PubMed
    Score: 0.002
  144. Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease. Dig Dis. 2018; 36(3):184-193.
    View in: PubMed
    Score: 0.002
  145. Non-specific gastrointestinal features: Could it be Fabry disease? Dig Liver Dis. 2018 May; 50(5):429-437.
    View in: PubMed
    Score: 0.002
  146. Performance of a new histology needle for EUS-guided fine needle biopsy: A retrospective multicenter study. Dig Liver Dis. 2018 May; 50(5):469-474.
    View in: PubMed
    Score: 0.002
  147. NutriCatt protocol in the Enhanced Recovery After Surgery (ERAS) program for colorectal surgery: The nutritional support improves clinical and cost-effectiveness outcomes. Nutrition. 2018 06; 50:74-81.
    View in: PubMed
    Score: 0.002
  148. Primary neoplasms of the small bowel at CT: a pictorial essay for the clinician. Eur Rev Med Pharmacol Sci. 2018 02; 22(3):598-608.
    View in: PubMed
    Score: 0.002
  149. A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis. Eur Rev Med Pharmacol Sci. 2018 02; 22(3):736-742.
    View in: PubMed
    Score: 0.002
  150. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. Drugs Today (Barc). 2018 Feb; 54(2):123-136.
    View in: PubMed
    Score: 0.002
  151. Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group. J Gastrointest Surg. 2018 05; 22(5):859-871.
    View in: PubMed
    Score: 0.002
  152. The ten commandments of chemoembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2018 01; 22(2):372-381.
    View in: PubMed
    Score: 0.001
  153. The Use of Probiotics in Different Phases of Diverticular Disease. Rev Recent Clin Trials. 2018; 13(2):89-96.
    View in: PubMed
    Score: 0.001
  154. Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever. Mediators Inflamm. 2017; 2017:7461426.
    View in: PubMed
    Score: 0.001
  155. Fecal microbiota transplantation: past, present and future perspectives. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):420-430.
    View in: PubMed
    Score: 0.001
  156. Dosimetric characterization of carbon fiber stabilization devices for post-operative particle therapy. Phys Med. 2017 Dec; 44:18-25.
    View in: PubMed
    Score: 0.001
  157. Endoscopic necrosectomy through a lumen-apposing metal stent resulting in perforation: is it time to develop dedicated accessories? Endoscopy. 2018 01; 50(1):79-80.
    View in: PubMed
    Score: 0.001
  158. Dental health in patients affected by alcohol use disorders: a cross-sectional study. Eur Rev Med Pharmacol Sci. 2017 Nov; 21(22):5021-5027.
    View in: PubMed
    Score: 0.001
  159. Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting. Int J Biol Markers. 2017 Oct 31; 32(4):e397-e402.
    View in: PubMed
    Score: 0.001
  160. Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort. Hepatology. 2017 12; 66(6):1814-1825.
    View in: PubMed
    Score: 0.001
  161. Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. Nutr Metab Cardiovasc Dis. 2018 04; 28(4):369-384.
    View in: PubMed
    Score: 0.001
  162. Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol. 2018 05; 53(5):567-572.
    View in: PubMed
    Score: 0.001
  163. Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network. PLoS One. 2017; 12(10):e0185728.
    View in: PubMed
    Score: 0.001
  164. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease. Int J Mol Sci. 2017 Sep 21; 18(10).
    View in: PubMed
    Score: 0.001
  165. Can We Predict the Efficacy of Anti-TNF-a Agents? Int J Mol Sci. 2017 Sep 14; 18(9).
    View in: PubMed
    Score: 0.001
  166. The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. Eur Rev Med Pharmacol Sci. 2017 Sep; 21(18):4014-4021.
    View in: PubMed
    Score: 0.001
  167. ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa. Anal Bioanal Chem. 2017 Oct; 409(26):6097-6111.
    View in: PubMed
    Score: 0.001
  168. Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study. J Vasc Interv Radiol. 2017 Sep; 28(9):1234-1239.
    View in: PubMed
    Score: 0.001
  169. Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin. Intern Emerg Med. 2017 Oct; 12(7):1059-1067.
    View in: PubMed
    Score: 0.001
  170. Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients. Biomed Res Int. 2017; 2017:3470893.
    View in: PubMed
    Score: 0.001
  171. Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease. Dig Liver Dis. 2017 Oct; 49(10):1098-1103.
    View in: PubMed
    Score: 0.001
  172. Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas. Eur Rev Med Pharmacol Sci. 2017 06; 21(12):2858-2874.
    View in: PubMed
    Score: 0.001
  173. Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World J Gastroenterol. 2017 May 14; 23(18):3195-3204.
    View in: PubMed
    Score: 0.001
  174. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection. Int J Mol Sci. 2017 May 12; 18(5).
    View in: PubMed
    Score: 0.001
  175. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply. Clin Microbiol Infect. 2017 11; 23(11):891.
    View in: PubMed
    Score: 0.001
  176. Primary Biliary Cholangitis: advances in management and treatment of the disease. Dig Liver Dis. 2017 Aug; 49(8):841-846.
    View in: PubMed
    Score: 0.001
  177. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population. Int J Biol Markers. 2017 May 04; 32(2):e190-e194.
    View in: PubMed
    Score: 0.001
  178. Efficacy and safety of very-low-calorie ketogenic diet: a double blind randomized crossover study. Eur Rev Med Pharmacol Sci. 2017 05; 21(9):2274-2289.
    View in: PubMed
    Score: 0.001
  179. Deep Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex in Alcohol Use Disorder Patients: Effects on Dopamine Transporter Availability and Alcohol Intake. Eur Neuropsychopharmacol. 2017 05; 27(5):450-461.
    View in: PubMed
    Score: 0.001
  180. Faecal microbiota transplantation in clinical practice. Gut. 2018 01; 67(1):196-197.
    View in: PubMed
    Score: 0.001
  181. Watery stools and metabolic acidosis. Intern Emerg Med. 2017 Jun; 12(4):487-492.
    View in: PubMed
    Score: 0.001
  182. Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. Eur Rev Med Pharmacol Sci. 2017 04; 21(7):1702-1708.
    View in: PubMed
    Score: 0.001
  183. Team work and cytopathology molecular diagnosis of solid pancreatic lesions. Dig Endosc. 2017 Sep; 29(6):657-666.
    View in: PubMed
    Score: 0.001
  184. Gut microbiota and inflammatory bowel disease: so far so gut! Minerva Gastroenterol Dietol. 2017 Dec; 63(4):373-384.
    View in: PubMed
    Score: 0.001
  185. Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports. Am J Kidney Dis. 2017 Aug; 70(2):297-300.
    View in: PubMed
    Score: 0.001
  186. Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. Eur Rev Med Pharmacol Sci. 2017 03; 21(1 Suppl):122-134.
    View in: PubMed
    Score: 0.001
  187. Fatty liver and drugs: the two sides of the same coin. Eur Rev Med Pharmacol Sci. 2017 03; 21(1 Suppl):86-94.
    View in: PubMed
    Score: 0.001
  188. Liver transplantation for drug-induced acute liver failure. Eur Rev Med Pharmacol Sci. 2017 03; 21(1 Suppl):37-45.
    View in: PubMed
    Score: 0.001
  189. Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. Eur Rev Med Pharmacol Sci. 2017 03; 21(1 Suppl):23-36.
    View in: PubMed
    Score: 0.001
  190. Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma. Oncotarget. 2017 Feb 28; 8(9):14408-14415.
    View in: PubMed
    Score: 0.001
  191. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. J Hepatol. 2017 07; 67(1):65-71.
    View in: PubMed
    Score: 0.001
  192. Ipilimumab Adjuvant Therapy in Melanoma. N Engl J Med. 2017 01 26; 376(4):398.
    View in: PubMed
    Score: 0.001
  193. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017 04; 66(4):569-580.
    View in: PubMed
    Score: 0.001
  194. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017 May; 23(5):337.e1-337.e3.
    View in: PubMed
    Score: 0.001
  195. May Gender or Ethnicity Affect Delta Over Baseline Values Obtained by 13-C Urea Breath Test? Rev Recent Clin Trials. 2017; 12(3):187-192.
    View in: PubMed
    Score: 0.001
  196. Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. Aliment Pharmacol Ther. 2017 01; 45(1):160-168.
    View in: PubMed
    Score: 0.001
  197. Extragastric Diseases and Helicobacter pylori. Helicobacter. 2015 Sep; 20 Suppl 1:40-6.
    View in: PubMed
    Score: 0.001
  198. Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives. Mediators Inflamm. 2013; 2013:391473.
    View in: PubMed
    Score: 0.001
  199. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). Radiol Med. 2013 Jun; 118(4):555-69.
    View in: PubMed
    Score: 0.001
  200. Endometriosis, need for a multidisciplinary clinical setting: the internist's point of view. Intern Emerg Med. 2010 Dec; 5(6):463-7.
    View in: PubMed
    Score: 0.001
  201. Effect of exogenous beta-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study. Eur J Clin Nutr. 2005 Apr; 59(4):489-93.
    View in: PubMed
    Score: 0.001
  202. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Aliment Pharmacol Ther. 1998 Jun; 12(6):539-43.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.